Skip to main content

Table 2.

Effect of GSK3α and/or GSK3β knockout using CRISPR/Cas9 approach on the survival of various lymphoma cell lines

Lymphoma line Null-knockout clones/total clones screened
GSK3α GSK3β GSK3α/β
OCI-LY1 9/17 19/24 6/13
OCI-LY19 20/28 0/24 nd
Jeko 7/12 0/24 nd
Mino 5/12 0/36 nd
Karpas299 12/20 0/26 nd

nd, not done.